California State University, San Bernardino
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, California State University, San Bernardino sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
California State University, San Bernardino: 3 sponsored US clinical trials, 1 recruiting.
California State University, San Bernardino sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is First Episode Psychosis, with 1 trials.
Upper-quartile sponsor footprint
California State University, San Bernardino sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
3 total, page 1 of 1
Microbiome Composition and Function Contributes to Cognitive Impairment and Neuroinflammation in Parkinson's Disease
NCT05419453
Optimizing Engagement in Services for First-Episode Psychosis
NCT05310838
Evaluation of the Positive Prevention PLUS Program
NCT02540278
Therapeutic Areas
What is open in the California State University, San Bernardino pipeline
1 recruiting of 3 indexed (33% open); 1 completed (33%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: First Episode Psychosis (1 trial), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
California State University, San Bernardino: open-pipeline peers nationwide
Peers matched on 3 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
California State University, San Bernardino sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 trials (± recruiting share)
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
- Actuated Medical · 33% recruiting · 3 trials
Related
What to do with this California State University, San Bernardino page
3 registered trials is a research-attention snapshot, not an endorsement of California State University, San Bernardino or any single study.
- 1 of California State University, San Bernardino's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- First Episode Psychosis is the condition California State University, San Bernardino studies most, compare against other sponsors active in the same condition before evaluating a specific study. See First Episode Psychosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. California State University, San Bernardino pipeline card: 3 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.